Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $92.7400 (-4.79%) ($92.0100 - $98.9570) on Mon. Oct. 19, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.32% (three month average) | RSI | 48 | Latest Price | $92.7400(-4.79%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.9% a day on average for past five trading days. | Weekly Trend | LGND declines -0.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(55%) IWO(53%) XBI(51%) IWM(49%) IWC(48%) | Factors Impacting LGND price | LGND will decline at least -1.16% in a week (0% probabilities). VIXM(-22%) UUP(-16%) VXX(-14%) UNG(-3%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.16% (StdDev 2.32%) | Hourly BBV | -2.3 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $98.04 | 5 Day Moving Average | $97.67(-5.05%) | 10 Day Moving Average | $100(-7.26%) | 20 Day Moving Average | $98.04(-5.41%) | To recent high | -26.8% | To recent low | 3.6% | Market Cap | $1.49b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |